Vaccination

Chile limits use of AstraZeneca after clot case

Chile on Thursday became the latest country to limit use of the AstraZeneca coronavirus vaccine, linked to rare blood clots, when a 31-year-old man developed thrombosis after being immunized.

Oncology & Cancer

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Diabetes

Dapagliflozin aids glycemic control in type 2 diabetes

(HealthDay) -- For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control, stabilized insulin dosing, and weight reductions, according to research ...

Vaccination

EU faces fresh shortfall of AstraZeneca vaccine supplies

The European Union is facing further shortfalls in its coronavirus inoculation programme after pharmaceutical giant AstraZeneca said production problems and export restrictions would reduce planned deliveries of its vaccine.

Vaccination

UK asks regulator to study AstraZeneca vaccine

The British government said on Friday it has asked its independent medicines regulator to assess AstraZeneca's coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.

Medications

FDA approves first 4-in-1 flu vaccine

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Vaccination

Vaccine stock in Italy stirs EU suspicions

AstraZeneca on Wednesday denied reports it was stockpiling coronavirus vaccines in the EU to export to Britain, after Italian inspectors found 29 million doses in a manufacturing plant.

page 7 from 34